Norris Medicines Stock Screener | Share Price & Fundamental Analysis
NORRIS
Trading & Distributors
Share Price BSE
₹15.00
▲
0.71 (4.97%)
Track Norris Medicines share price live with TickJournal's free stock screener.
Analyze Norris Medicines share price history trends and compare 52-week high low
levels.
Calculate NORRIS stock fair value using fundamental analysis and view live share price charts.
Determine Norris Medicines share intrinsic value and compare it with current NORRIS share price.
Record your Norris Medicines trades in TickJournal's free trading journal and track your portfolio performance.
Norris Medicines Market Cap
₹16.29 Cr.
NORRIS P/E Ratio (TTM)
15.00
EPS (TTM)
₹-1.24
Dividend Yield
-
Debt to Equity
-
NORRIS 52 Week High
₹21.06
Norris Medicines 52 Week Low
₹12.75
Operating Margin
-8.00%
Profit Margin
-28.57%
NORRIS Revenue (TTM)
₹7.00
EBITDA
₹-1.00
Net Income
₹-2.00
Total Assets
₹14.00
Total Equity
₹-15.00
Norris Medicines Share Price History - Stock Screener Chart
Screen NORRIS historical share price movements with interactive charts. Analyze price trends and patterns.
Norris Medicines Company Profile - Fundamental Screener
Screen Norris Medicines company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for NORRIS shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE744C01029
Norris Medicines Balance Sheet Screener
Screen NORRIS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 |
| Current Assets | 6 | 6 | 5 | 4 | 8 | 7 | 7 | 8 | 9 | 7 |
| Fixed Assets | 5 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 10 | 8 |
| Liabilities | ||||||||||
| Total Liabilities | 14 | 14 | 14 | 14 | 20 | 21 | 20 | 21 | 22 | 18 |
| Current Liabilities | 19 | 19 | 18 | 18 | 16 | 15 | 11 | 8 | 8 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | -15 | -14 | -12 | -11 | -7 | -3 | 0 | 2 | 5 | 5 |
| Share Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves & Surplus | -25 | -24 | -22 | -21 | -17 | -12 | -10 | -8 | -5 | -5 |
Norris Medicines Income Statement Screener - Profit & Revenue Analysis
Screen Norris Medicines income statement and profit fundamentals.
Analyze NORRIS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Norris Medicines share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 6 | 6 | 8 | 10 | 12 | 8 | 16 | 14 | 21 | 19 | 19 |
| Expenses | 8 | 6 | 6 | 7 | 10 | 14 | 10 | 17 | 16 | 21 | 18 | 17 |
| EBITDA | -1 | 0 | 0 | 1 | 0 | -2 | -2 | -1 | -2 | 0 | 1 | 2 |
| Operating Profit % | -8.00% | -5.00% | -3.00% | 11.00% | -1.00% | -14.00% | -27.00% | -4.00% | -14.00% | 0.00% | 4.00% | 9.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 0 | 0 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | -2 | -1 | -1 | -1 | -2 | -4 | -4 | -2 | -3 | -1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 1 | 1 | -1 | 0 | -1 | 0 | 0 | 1 |
| Net Profit | -2 | -1 | -1 | -2 | -3 | -5 | -3 | -2 | -3 | -1 | 0 | -1 |
| EPS | -1.50 | -1.24 | -1.19 | -1.75 | -3.26 | -4.96 | -2.84 | -1.68 | -2.51 | -0.77 | 0.04 | -1.04 |
Norris Medicines Cash Flow Screener - Liquidity Fundamentals
Screen NORRIS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1 | 0 | 1 | -1 | 1 | -3 | -2 | 1 | -1 | 1 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | 0 |
| Financing Activities | -1 | 0 | -1 | 1 | -1 | 3 | 2 | -1 | 3 | -1 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Norris Medicines Shareholding Pattern Screener
See Norris Medicines shareholding pattern with promoter, FII, and DII holdings.
Check Norris Medicines promoter holding and ownership changes for NORRIS on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 34.00% | 34.00% | 34.00% | 34.01% | 34.01% | 34.01% | 34.00% | 34.04% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% | 0.07% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.76% | 20.78% | 20.79% | 20.70% | 20.71% | 20.72% | 20.73% | 20.56% |
| Other Holding | 45.17% | 45.15% | 45.14% | 45.22% | 45.21% | 45.20% | 45.21% | 45.33% |
| Shareholder Count | 25,815 | 25,950 | 25,895 | 25,517 | 25,400 | 25,498 | 25,659 | 25,326 |
Norris Medicines Share Dividend Screener - Share Yield Analysis
Check Norris Medicines dividend history with payout and yield data.
View Norris Medicines dividend details including ex-dates and amounts for NORRIS stock.
Norris Medicines Stock Index Membership
See which indices include Norris Medicines stock.
Check NORRIS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Norris Medicines Market Events Screener - Corporate Actions
Get Norris Medicines corporate actions including splits, bonuses, and buybacks.
Check Norris Medicines stock events that may affect NORRIS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.97% | ||
| Annual General Meeting | NA | 3.69% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -0.42% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 2.16% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 6.26% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -2.88% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 15.67% |
| 2024-01-30 | 2024-01-30 | Extraordinary General Meeting | NA | 66.24% |
| 2023-12-14 | 2023-12-14 | Annual General Meeting | NA | 9.29% |
Norris Medicines Competitors Screener - Peer Comparison
Screen NORRIS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,487 | 11.17 | 99,562 | 11.11% | 1,821 | 47.63 |
| Elitecon International | 17,352 | 74.19 | 551 | 55040.00% | 70 | 45.97 |
| MMTC | 8,472 | 37.59 | 263 | 28.63% | 87 | 42.29 |
| BN Agrochem | 3,676 | 55.03 | 367 | 5071.83% | 20 | 50.10 |
| MSTC | 3,361 | 7.89 | 388 | -25.38% | 407 | 46.44 |
| Ravindra Energy | 2,966 | 42.96 | 262 | 79.10% | 23 | 57.50 |
| TCC Concept | 2,040 | 45.22 | 90 | 14.72% | 42 | 36.38 |
| Vintage Coffee & Beverages | 2,028 | 37.69 | 313 | 136.92% | 40 | 42.32 |
| RRP Defense | 1,259 | 506.53 | 11 | -16.00% | 1 | 70.39 |
| Creative Newtech | 1,111 | 18.58 | 1,802 | 3.48% | 53 | 56.62 |
Norris Medicines Company Announcements - News Screener
Screen NORRIS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-01 | Announcement under Regulation 30 (LODR)-Resignation of Director | View |
| 2026-03-01 | Intimation Regarding Completion Of NAFDAC Audit (Nigeria) Of Norris Medicines Limited. | View |
| 2025-12-11 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Friday November 14 2025 | View |
| 2025-11-08 | Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI Listing Obligation And Disclosure Requirements 2015 For Holding Board Meeting For Approval Of Un-Audited Financial Results For The Quarter Ended September 30Th 2025 And Other Matters. | View |
| 2025-10-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Voting Results For 34Th AGM. | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Proceedings Of The 34Th Annual General Meeting Of Norris Medicines Limited Held For The Financial Year 2024-2025 On September 29Th 2025. | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-25 | Closure of Trading Window | View |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-05 | Intimation Of Cutoff Date For Remote E-Voting And Closure Of Register Of Members & Share Transfer Books At 34Th Annual General Meeting. | View |
| 2025-09-05 | Letter To Shareholders In Terms Of Regulation 36(1)(B) Of The SEBI Listing Regulations. | View |
| 2025-09-05 | Reg. 34 (1) Annual Report. | View |
| 2025-09-05 | Notice Of 34Th Annual General Meeting Of The Company. | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-01 | Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 01St September 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-08-14 | Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |
| 2025-08-14 | Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 14Th August 2025 Pursuant To Regulation 30 And Regulation 33 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. | View |